Omics Nextgen Laboratories Private Limited
Founded in 2021 and headquartered in Andhra Pradesh, India.
2021 | Godavari, Andhra Pradesh (India) | Active
Omics Nextgen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Omics Nextgen Laboratories
Omics Nextgen Laboratories Private Limited (ONLPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 May 2021 (Three years and eight months 29 days old ). Its registered office is in Godavari, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madhu Pulagam and Murali Kommula serve as directors at the Company.
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110AP2021PTC118398
- Company No.
118398
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Healthcare
Who are the key members and board of directors at Omics Nextgen Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Pulagam  | Director | 29-May-2021 | Current |
| Murali Kommula | Director | 29-May-2021 | Current |
Financial Performance of Omics Nextgen Laboratories.
Enhance accessibility to Omics Nextgen Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Omics Nextgen Laboratories?
Unlock access to Omics Nextgen Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Drdiagnomics Private Limited
Madhu Pulagam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Omics Nextgen Laboratories?
Omics Nextgen Laboratories has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omics Nextgen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omics Nextgen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.